Researchers have revealed the mechanism underlying GPCR function using a GPS nuclear magnetic resonance (NMR) technique.

Novo Nordisk has contracted California-based biotech Septerna to develop oral pills that target G protein-coupled receptors.

Persistent volatility has plagued the S&P 500 for much of 2025, prompting widespread caution among many investors amid the ...

Evotec's insights into GPCRs and waveRAPID technology reveal new opportunities in drug discovery, focusing on orphan ...

Leitner studies how energy flows through molecules, especially in biological systems like protein complexes. Being named ...

Braskem is considering expanding its ethylene cracker and polyethylene complex in the Brazilian state of Rio de Janeiro by ...

"We are excited to be entering into this collaboration with Synfini to accelerate drug discovery around a publicly available high-value target,” said Helena Mancebo, CEO of Multispan. "By using ...

Tectonic Therapeutic, Inc. (NASDAQ: TECX) has announced the complete results from part A of the phase 1b clinical trial of TX45 in patients with group 2 pulmonary hypertension in heart failure with ...

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

Among the more unconventional options for treating long COVID, nicotine – delivered via low-dose transdermal patches – has ...

Taste, pain, or response to stress—nearly all essential functions in the human body are regulated by molecular switches ...

Prostaglandin E2 (PGE2), a bioactive lipid derived from arachidonic acid, mediates a broad range of physiological processes ...